Current state and clinical outcome in Turkish patients with hepatocellular carcinoma

doi:10.4254/wjh.v10.i1.51

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6213)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

431

WORD

293

HTML

3144

Figures (1-2)

230

Tables (1-5)

232

Sum=4330

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

980

Download

903

Sum=1883

Jan 27, 2018 (publication date) through Jan 12, 2025

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Jan 27, 2018; 10(1): 51-61
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.51

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall survival in patients with hepatocellular carcinoma. A: Overall median survival in the whole cohort; B: Survival curves was stratified by primary treatment modality.

Open in New Tab Full Size Figure Download Figure

Figure 2 Overall survival according to oncological stage and pre-diagnostic screening characteristics. Patients within Milan (A) or expanded criteria (B), patients who were diagnosed at earlier BCLC stages (C) and patients who had regular follow-up screening for HCC (D) had a significantly better survival (log-rank, P < 0.001). HCC: Hepatocellular carcinoma; BCLC: Barcelona Clinic Liver Cancer.

Citation: Ekinci O, Baran B, Ormeci AC, Soyer OM, Gokturk S, Evirgen S, Poyanli A, Gulluoglu M, Akyuz F, Karaca C, Demir K, Besisik F, Kaymakoglu S. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma. World J Hepatol 2018; 10(1): 51-61
URL: https://www.wjgnet.com/1948-5182/full/v10/i1/51.htm
DOI: https://dx.doi.org/10.4254/wjh.v10.i1.51